| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. | Director | Stock option (right to buy) | 20,001 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SNOA | Sonoma Pharmaceuticals, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Director | 02 Jan 2026, 17:20 |
| SNOA | Sonoma Pharmaceuticals, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Director | 03 Jan 2025, 17:02 |
| SNOA | Sonoma Pharmaceuticals, Inc. | 29 Dec 2022 | 1 | $0 | 4 | Director | 30 Dec 2022, 16:00 |
| SNOA | Sonoma Pharmaceuticals, Inc. | 14 Jan 2022 | 1 | $0 | 4 | Director | 14 Jan 2022, 19:31 |